Analyzing Clinical Trial Experiences of Prostate Cancer Patients
Not yet recruiting
- Conditions
- Prostate Cancer
- Registration Number
- NCT05411354
- Lead Sponsor
- Power Life Sciences Inc.
- Brief Summary
Participation in clinical trials usually favors a particular demographic group. But there is limited research available to explain what trial attributes affect the participation or completion of these specific demographic groups.
This study will admit a wide range of data on the clinical trial experience of Prostate Cancer patients to determine which factors prevail in limiting a patient's ability to join or finish a trial.
It will also try to analyze data from the perspective of different demographic groups to check for recurring trends which might shed insights for the sake of future Prostate Cancer patients.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- NOT_YET_RECRUITING
- Sex
- Male
- Target Recruitment
- 400
Inclusion Criteria
- Patient has been diagnosed with Prostate Cancer as identified by imaging
- Patient has self-identified as planning to enroll in an interventional clinical trial for Prostate Cancer
- Patient is at least 18 years of age
Exclusion Criteria
- Patient does not understand, sign, and return consent form
- Inability to perform regular electronic reporting
- Patient has a ECOG score of 4
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Rate of patients who decide to enroll in a Prostate Cancer Clinical Trial 3 months Number of patients who remain in Prostate Cancer clinical trial until completion of clinical trial 12 months
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Power Life Sciences
🇺🇸San Francisco, California, United States